The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab.
Saved in:
| Title: | The third dose of BNT162b2 COVID-19 vaccine is efficacious and safe for systemic lupus erythematosus patients receiving belimumab. |
|---|---|
| Authors: | Tunitsky-Lifshitz, Yulia1,2, Maoz-Segal, Ramit1, Niznik, Stanley1, Shavit, Ronen1, Yahia, Soad Haj1,2, Langevitz, Pnina2,3, Agmon-Levin, Nancy1,2 nancy.agmonlevin@sheba.health.gov.il |
| Source: | Lupus. Apr2023, Vol. 32 Issue 5, p675-679. 5p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09612033 |
|---|---|
| DOI: | 10.1177/09612033231164262 |
